ESR2 and breast carcinoma: RNA-ChIP with MALAT1 (Fig. 2b) revealed a differential response: interaction between MALAT1 and ERβ in PCa cells and or between MALAT1 and ERα in breast cancer cells, both detectable in basal condition, was not affected by E2 treatment.